- Home
- CNTA vs CRGY Comparison
CNTA vs CRGY Comparison
Compare CNTA & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- CRGY
- Stock Information
- Founded
- CNTA 2020
- CRGY 1986
- Country
- CNTA United Kingdom
- CRGY United States
- Employees
- CNTA N/A
- CRGY N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- CRGY Oil & Gas Production
- Sector
- CNTA Health Care
- CRGY Energy
- Exchange
- CNTA Nasdaq
- CRGY Nasdaq
- Market Cap
- CNTA 1.6B
- CRGY 2.5B
- IPO Year
- CNTA 2021
- CRGY N/A
- Fundamental
- Price
- CNTA $13.07
- CRGY $8.63
- Analyst Decision
- CNTA Strong Buy
- CRGY Buy
- Analyst Count
- CNTA 10
- CRGY 12
- Target Price
- CNTA $28.78
- CRGY $16.40
- AVG Volume (30 Days)
- CNTA 1.2M
- CRGY 3.5M
- Earning Date
- CNTA 08-12-2025
- CRGY 08-04-2025
- Dividend Yield
- CNTA N/A
- CRGY 5.57%
- EPS Growth
- CNTA N/A
- CRGY N/A
- EPS
- CNTA N/A
- CRGY N/A
- Revenue
- CNTA $15,000,000.00
- CRGY $3,223,618,000.00
- Revenue This Year
- CNTA N/A
- CRGY $25.73
- Revenue Next Year
- CNTA N/A
- CRGY N/A
- P/E Ratio
- CNTA N/A
- CRGY N/A
- Revenue Growth
- CNTA 118.88
- CRGY 31.58
- 52 Week Low
- CNTA $8.46
- CRGY $6.83
- 52 Week High
- CNTA $19.09
- CRGY $16.94
- Technical
- Relative Strength Index (RSI)
- CNTA 52.42
- CRGY 50.03
- Support Level
- CNTA $12.74
- CRGY $8.48
- Resistance Level
- CNTA $14.27
- CRGY $9.61
- Average True Range (ATR)
- CNTA 0.68
- CRGY 0.34
- MACD
- CNTA 0.11
- CRGY -0.06
- Stochastic Oscillator
- CNTA 55.99
- CRGY 38.36
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.